Recent studies have provided evidence for using magnetic resonance imaging (MRI) active lesions as surrogate for relapses and disability progression in multiple sclerosis (MS). However, the validity of MRI metrics as surrogate endpoints in MS is controversial. Furthermore, the extrapolation of previous results to novel therapies is not warranted. We tested here the validity of MRI surrogacy in MS studies on recently published trials of oral drugs. The 92% of observed effects of oral drugs on clinical outcomes resulted close to those predicted by MRI active lesions. This further validates MRI surrogacy in MS, with important implications for future trials planning.

Sormani, M., Bonzano, L., Roccatagliata, L., DE STEFANO, N. (2011). Magnetic resonance imaging as surrogate for clinical endpoints in multiple sclerosis: data on novel oral drugs. MULTIPLE SCLEROSIS, 17(5), 630-633 [10.1177/1352458510393770].

Magnetic resonance imaging as surrogate for clinical endpoints in multiple sclerosis: data on novel oral drugs

DE STEFANO, NICOLA
2011-01-01

Abstract

Recent studies have provided evidence for using magnetic resonance imaging (MRI) active lesions as surrogate for relapses and disability progression in multiple sclerosis (MS). However, the validity of MRI metrics as surrogate endpoints in MS is controversial. Furthermore, the extrapolation of previous results to novel therapies is not warranted. We tested here the validity of MRI surrogacy in MS studies on recently published trials of oral drugs. The 92% of observed effects of oral drugs on clinical outcomes resulted close to those predicted by MRI active lesions. This further validates MRI surrogacy in MS, with important implications for future trials planning.
2011
Sormani, M., Bonzano, L., Roccatagliata, L., DE STEFANO, N. (2011). Magnetic resonance imaging as surrogate for clinical endpoints in multiple sclerosis: data on novel oral drugs. MULTIPLE SCLEROSIS, 17(5), 630-633 [10.1177/1352458510393770].
File in questo prodotto:
File Dimensione Formato  
187.pdf

non disponibili

Tipologia: Post-print
Licenza: NON PUBBLICO - Accesso privato/ristretto
Dimensione 125.69 kB
Formato Adobe PDF
125.69 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11365/11101
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo